Breaking news

COVID-19 TREATMENT In this report, the authors describe outcomes in a cohort of patients hospitalized for severe Covid-19 who were treated with remdesivir on a compassionate-use basis. Remdesivir is a prodrug of a nucleotide analogue that is intracellularly metabolized to… Continue Reading

COVID-19 TREATMENT In this nice narrative review just published in JAMA, the authors summarize current evidence regarding major proposed treatments, repurposed or experimental, for COVID-19 and provides a summary of current clinical experience and treatment guidance for this novel epidemic… Continue Reading

Screening of myelin-oligodendrocyte-glycoprotein (MOG) antibodies in a large prospective pediatric cohort  with demyelinating syndromes or other encephalitis showed surprisingly high rate of positive results. The study showed implications on diagnostic and therapeutic strategies

The European Medicines Agency has recommended that the multiple sclerosis medicine Gilenya (fingolimod) must not be used in pregnant women and in women able to have children who are not using effective contraception. If a woman becomes pregnant while using Gilenya, the medicine must be stopped and the pregnancy will have to be closely monitored. This is because the active substance in Gilenya, fingolimod, can harm the unborn baby and may cause birth defects.

Aiming for treatment they have spent more than 30 years describing, understanding and diagnosing the most common hereditary form of stroke, CADASIL. For this, the four French neuroscientists are now receiving the world's most valuable prize for brain research – the Lundbeck Foundation Brain Prize, worth 1 million euros.

The Guidelines of the Spanish Neurological Society have been included in our Guideline Reference Centre. Take a look here ! You can filter by language and issuing body. We are currently working on including all national neurological guidelines from our member societies! We will keep you updated.

Members of the Scientific Panel on Sleep-Wake disorders (LaTorre et al.) have published an article on "T cells in patients with narcolepsy target self-antigens of hypocretin neurons" in Nature Neurology. You can find the article here.